Company / CapEx per Share
Xeris Biopharma Holdings, Inc. CapEx per Share History
FY2020-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.03
FY2021
5-year range
$0.03 / $0.03
FY2020-FY2021
Trend
+187.8%
vs FY2020
Sector context
#91 of 192
Health Care
What the data says
At $0.03, Xeris Biopharma Holdings, Inc.'s capex per share ranks #91 of 192 in the Health Care sector.
Based on SEC 10-K filings.
0.03 in FY2021.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#91 of 192 in Health CareTop 47% of 192This company $0.03 Sector average $3.54
▼
-99.3% below sector average
Key checks
Key Insights
- In FY2021, capex per share increased 187.8% year-over-year.
- Ranks #91 out of 192 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.26 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $0.03 | +187.8% |
| FY2020 | $0.01 | - |
As of FY2021 · SEC 10-K · Updated Jun 30, 2026